Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Myosin 9 Antikörper

MYH9 Reaktivität: Human, Maus, Ratte, Drosophila melanogaster WB, ELISA, ICC Wirt: Human Monoclonal SF9 unconjugated Recombinant Antibody
Produktnummer ABIN1169007
  • Target Alle Myosin 9 (MYH9) Antikörper anzeigen
    Myosin 9 (MYH9)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 85
    • 34
    • 31
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte, Drosophila melanogaster
    Wirt
    • 73
    • 11
    • 1
    • 1
    • 1
    Human
    Klonalität
    • 73
    • 14
    Monoklonal
    Konjugat
    • 39
    • 9
    • 6
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    Dieser Myosin 9 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 42
    • 14
    • 14
    • 13
    • 11
    • 8
    • 5
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunocytochemistry (ICC)
    Spezifität
    Recognizes human, mouse, rat and drosophila myosin IIA (heavy chain).
    Kreuzreaktivität
    Fruchtfliege (Drosophila melanogaster), Human, Maus, Ratte (Rattus)
    Aufreinigung
    Purified from HEK 293 cell culture supernatant.
    Reinheit
    >95 % (SDS-PAGE)
    Immunogen
    Full length myosin IIA from rat liver.
    Klon
    SF9
    Isotyp
    IgG2
    Top Product
    Discover our top product MYH9 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Kommentare

    anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    In PBS containing 10 % glycerol and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 month after receipt when stored at +4°C. Stable for at least 1 year after receipt when stored at -20°C.
    Haltbarkeit
    12 months
  • Target
    Myosin 9 (MYH9)
    Andere Bezeichnung
    Myosin IIA (MYH9 Produkte)
    Synonyme
    BDPLT6 antikoerper, DFNA17 antikoerper, EPSTS antikoerper, FTNS antikoerper, MHA antikoerper, NMHC-II-A antikoerper, NMMHC-IIA antikoerper, NMMHCA antikoerper, C80049 antikoerper, D0Jmb2 antikoerper, E030044M24Rik antikoerper, Fltn antikoerper, Myhn-1 antikoerper, Myhn1 antikoerper, NMHC II-A antikoerper, NMHCIIA antikoerper, NMMHC II-a antikoerper, NMMHC-A antikoerper, TU72.6 antikoerper, fi22c04 antikoerper, myh9 antikoerper, myh9l2 antikoerper, wu:fi22c04 antikoerper, wu:fj85e11 antikoerper, zgc:162029 antikoerper, zgc:66164 antikoerper, NMMHC antikoerper, myosin antikoerper, non-muscle antikoerper, nonmuscle antikoerper, KLG/PTK7 antikoerper, dfna17 antikoerper, epsts antikoerper, ftns antikoerper, nmhc-ii-a antikoerper, nmmhca antikoerper, myosin heavy chain 9 antikoerper, myosin, heavy polypeptide 9, non-muscle antikoerper, myosin, heavy chain 9a, non-muscle antikoerper, myosin, heavy chain 9, non-muscle antikoerper, myosin, heavy chain 9, non-muscle L homeolog antikoerper, MYH9 antikoerper, Myh9 antikoerper, myh9a antikoerper, myh9.L antikoerper
    Hintergrund
    Anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.
    UniProt
    P35579
    Pathways
    Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
Sie sind hier:
Kundenservice